Matsuoka H, Mizuno T, Sakai M, Suzuki K, et al. The Effect and Tolerability of Second-line Chemotherapy Are Associated With Disease Control by Nivolumab Chemotherapy in Patients With Gastric Cancer. Anticancer Res 2022;42:4973-4980.
PMID: 36191980